M&As this week: Otsuka Pharmaceutical Factory, Sygnis
Otsuka Pharmaceutical Factory has signed an agreement to acquire 20% of outstanding shares in Otsuka Pharmaceutical India Private (OPI).
The shares are currently held by Claris Lifesciences, a pharmaceutical company based in India.
Based in Japan, the acquirer company manufactures and distributes industrial and pharmaceutical chemicals.
The purchase consideration for the acquisition is $20m.
German biopharmaceutical company Sygnis has agreed to acquire UK-based Innova Biosciences.
The purchase consideration for the acquisition will include €8m ($8.79m) in cash and up to 3.5 million in shares.